Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Hatyai, Songkhla, Thailand.
Translational Medicine Research Center, Faculty of Medicine, Prince of Songkla University, Hatyai, Songkhla, Thailand.
Am J Case Rep. 2022 Jun 26;23:e935921. doi: 10.12659/AJCR.935921.
BACKGROUND Juvenile hyaline fibromatosis is a rare autosomal recessive disorder with unknown prevalence characterized by abnormal development of hyalinized fibrous tissue usually in the skin, mucosa, bone, and often the internal organs. Here, we report the case of a 7-year-old girl from a family with ANTXR2 mutation confirming JHF. CASE REPORT The girl presented with multiple painless soft-tissue swellings affecting the ears, forehead, and scalp. Excisional biopsies of the masses reported positive immunohistochemical staining for collagen type VI in the extracellular matrix area, which indicated collagen VI accumulation. Genetic analysis was performed using whole-exome sequencing. The variants were further validated using Sanger sequencing in trio-based approach. We identified a novel mutation, c.1273_1293delinsTCTTGTGGGTTTGGCT in exon 15 of ANTXR2 gene, leading to a frameshift of the amino acid from codon 425 to all the rest of the amino acid chain (p.Pro425Serfs). The change of an encoded protein interrupted lysosome-mediated degradation of collagen VI. This finding was compatible with her parents whose genetic tests were both positive for the same heterogenous deletion/insertion mutation. The patient was treated with surgical excision of the tumor masses, which had to be repeated several times due to recurrences. CONCLUSIONS This novel mutation in exon 15 of the ANTXR2 gene may help improve understanding of genotype-phenotype correlations for this syndrome and provide the basis for diagnostic testing. A multidisciplinary team approach including genetic molecular testing is required for an accurate diagnosis and management of JHF for conducting genetic counseling for affected families as a part of holistic management.
幼年性透明纤维瘤病是一种罕见的常染色体隐性遗传病,其发病率未知,其特征是透明纤维组织异常发育,通常发生在皮肤、黏膜、骨骼,常累及内脏器官。本文报道了一例 ANTXR2 基因突变证实为幼年性透明纤维瘤病的 7 岁女孩病例。
该女孩表现为多个无痛性软组织肿块,累及耳朵、额头和头皮。肿块的切除活检报告示细胞外基质区胶原 VI 阳性免疫组化染色,提示胶原 VI 蓄积。采用外显子组测序进行基因分析。采用基于三人体系的 Sanger 测序对变体进行进一步验证。我们在 ANTXR2 基因的外显子 15 中发现了一个新的突变 c.1273_1293delinsTCTTGTGGGTTTGGCT,导致从密码子 425 开始的氨基酸全部发生移码(p.Pro425Serfs)。该改变导致编码蛋白的中断,使胶原 VI 无法进行溶酶体介导的降解。这一发现与她的父母相符,他们的基因检测均为同一杂合性缺失/插入突变阳性。患者接受了肿瘤肿块的手术切除,但由于复发,不得不多次重复手术。
ANTXR2 基因外显子 15 的这一新突变可能有助于提高对该综合征的基因型-表型相关性的认识,并为诊断检测提供依据。对于 JHF 的准确诊断和管理,需要多学科团队方法,包括遗传分子检测,以进行遗传咨询并为受影响的家庭提供整体管理的一部分。